SynthesisPharmacoEconomics2011
A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.
Synthesis in PharmacoEconomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.
- Pooled it
- A review of the methods used to estimate the cost of Alzheimer's disease in the United States.American journal of Alzheimer's disease and other dementias · 2011Pooled it
- Assistive technology and telecare to maintain independent living at home for people with dementia: the ATTILA RCT.Health technology assessment (Winchester, England) · 2021Trial
- The Financial Risks of Unpaid Caregiving During the COVID-19 Pandemic: Results From a Self-reported Survey in a Canadian Jurisdiction.Health services insights · 2023Article
- Economic Burden of Epidermolysis Bullosa Disease in Iran.Medical journal of the Islamic Republic of Iran · 2021Article
- Medicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community.The journals of gerontology. Series B, Psychological sciences and social sciences · 2020Article
- The economic burden of dementia in China, 1990-2030: implications for health policy.Bulletin of the World Health Organization · 2017Article
- The association between caregiver well-being and care provided to persons with Alzheimer's disease and related disorders.BMC research notes · 2016Article
- Using U.S. Medicare records to evaluate the indirect health effects on spouses: a case study in Alzheimer's disease patients.BMC health services research · 2014Article
- Impact of dementia on payments for long-term and acute care in an elderly cohort.Medical care · 2013Article
- Errors in self-reports of health services use: impact on alzheimer disease clinical trial designs.Alzheimer disease and associated disordersArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A systematic review of dementia cost-of-illness (COI) studies in the US and Canada was conducted to explore the policy-making relevance of these studies. MEDLINE, CINAHL, EconLit, AMED and the Cochrane Library were searched from inception to March 2010 for English-language COI articles. Content analysis was used to extract common themes about dementia cost from the conclusions of articles that passed title, abstract and full-text screening. These themes informed our exploration of the policy-making relevance of COI studies in dementia. The literature search retrieved 961 articles and data were extracted from 46 articles. All except three articles reported data from the US; 27 articles included Alzheimer's dementia only. Common themes pertained to general observations about dementia cost, cost drivers in dementia, caregiver cost, items that may lower dementia cost, social service cost, Medicare and Medicaid cost, and cost comparisons with other diseases. The common themes suggest policy-oriented research for the future. However, the extracted COI studies were typically not conducted for policy-making purposes and they did not commonly provide prescriptive policy options. Researchers and policy makers need to consider whether the optimal research focus in dementia should be on programme evaluations instead of more COI studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.